High-density lipoproteins neutralize C-reactive protein proinflammatory activity

被引:139
作者
Wadham, C
Albanese, N
Roberts, J
Wang, LJ
Bagley, CJ
Gamble, JR
Rye, KA
Barter, PJ
Vadas, MA
Xia, P
机构
[1] Inst Med & Vet Sci, Div Human Immunol, Hanson Inst, Adelaide, SA 5000, Australia
[2] Univ Adelaide, Adelaide, SA, Australia
[3] Heart Res Inst, Lipid Res Grp, Camperdown, NSW, Australia
关键词
lipoproteins; protein; inflammation; atherosclerosis;
D O I
10.1161/01.CIR.0000127419.45975.26
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-C-reactive protein (CRP), a well-recognized marker of atherosclerosis, has recently been suggested to have a direct proinflammatory effect. The constitutive expression of low levels of CRP in normal plasma suggests the likelihood that a natural factor exists to neutralize the effect of CRP. This factor(s) has not yet been identified. Method and Results - The proinflammatory effect of CRP was measured by the induction of inflammatory adhesion molecules in human umbilical vein endothelial cells (HUVECs). We show that CRP significantly induced upregulation of adhesion molecules in both protein and mRNA levels. The CRP-induced expression of these inflammatory adhesion molecules was completely suppressed when the cells were preincubated with a physiological concentration ( 1 mg/mL apolipoprotein A-I) of HDLs derived from human plasma (native HDL) or reconstituted HDL (rHDL) at a very low concentration (0.01 mg/mL apolipoprotein A-I). A novel mechanism of HDL inhibition is likely to operate, because ( 1) rHDL was 100 times more potent than native HDL, ( 2) preincubation with HDL and its sustained presence were obligatory, and ( 3) oxidized 1-palmitoyl-2-linoleoyl-sn-glycero-3-phosphocholine was the fundamental active component. Conclusions - The CRP-induced upregulation of inflammatory adhesion molecules in HUVECs was completely prevented by HDL via their oxidized phospholipid components.
引用
收藏
页码:2116 / 2122
页数:7
相关论文
共 28 条
[1]   Factors influencing the ability of HDL to inhibit expression of vascular cell adhesion molecule-1 in endothelial cells [J].
Ashby, DT ;
Rye, KA ;
Clay, MA ;
Vadas, MA ;
Gamble, JR ;
Barter, PJ .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1998, 18 (09) :1450-1455
[2]  
Baker PW, 2000, J LIPID RES, V41, P1261
[3]   The major receptor for C-reactive protein on leukocytes is Fcγ receptor II [J].
Bharadwaj, D ;
Stein, MP ;
Volzer, M ;
Mold, C ;
Du Clos, TW .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 190 (04) :585-590
[4]   Protective role of phospholipid oxidation products in endotoxin-induced tissue damage [J].
Bochkov, VN ;
Kadl, A ;
Huber, J ;
Gruber, F ;
Binder, BR ;
Leitinger, N .
NATURE, 2002, 419 (6902) :77-81
[5]   Ageing, tumour necrosis factor-alpha (TNF-α) and atherosclerosis [J].
Bruunsgaard, H ;
Skinhoj, P ;
Pedersen, AN ;
Schroll, M ;
Pedersen, BK .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2000, 121 (02) :255-260
[6]   C-reactive protein, insulin resistance, central obesity, and coronary heart disease risk in Indian Asians from the United Kingdom compared with European whites [J].
Chambers, JC ;
Eda, S ;
Bassett, P ;
Karim, Y ;
Thompson, SG ;
Gallimore, JR ;
Pepys, MB ;
Kooner, JS .
CIRCULATION, 2001, 104 (02) :145-150
[7]   C-reactive protein binds to both oxidized LDL and apoptotic cells through recognition of a common ligand: Phosphorylcholine of oxidized phospholipids [J].
Chang, MK ;
Binder, CJ ;
Torzewski, M ;
Witztum, JL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (20) :13043-13048
[8]   Time sequence of the inhibition of endothelial adhesion molecule expression by reconstituted high density lipoproteins [J].
Clay, MA ;
Pyle, DH ;
Rye, KA ;
Vadas, MA ;
Gamble, JR ;
Barter, PJ .
ATHEROSCLEROSIS, 2001, 157 (01) :23-29
[9]   HIGH-DENSITY-LIPOPROTEINS INHIBIT CYTOKINE-INDUCED EXPRESSION OF ENDOTHELIAL-CELL ADHESION MOLECULES [J].
COCKERILL, GW ;
RYE, KA ;
GAMBLE, JR ;
VADAS, MA ;
BARTER, PJ .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1995, 15 (11) :1987-1994
[10]  
GAMBLE JR, 1993, J IMMUNOL, V150, P4494